Source comparison
MK-677 Alternative to HGH Injections: Side-by-Side Comparison
Mechanism Ghrelin receptor agonist → endogenous GH release Exogenous synthetic somatropin → direct GH replacement MK-677 preserves pituitary feedback; HGH bypasses it entirely Administration Oral (capsule or liquid) Subcutaneous or intramuscular injection MK-6
This comparison does not assign a generated winner or score.
- Mechanism
- Ghrelin receptor agonist → endogenous GH release
- Exogenous synthetic somatropin → direct GH replacement
- MK-677 preserves pituitary feedback; HGH bypasses it entirely
- Administration
- Oral (capsule or liquid)
- Subcutaneous or intramuscular injection
- MK-677 eliminates injection protocol, sharps disposal, refrigeration
- Half-Life
- 4–6 hours (GH elevation lasts 6–8 hours)
- 2.5–4 hours (requires daily dosing for stable levels)
- Both require consistent dosing; MK-677 once-daily, HGH typically daily or EOD
- IGF-1 Response
- Sustained elevation (39–89% increase at 25mg daily) after 4–6 weeks
- Immediate, dose-dependent elevation within 24 hours
- HGH offers faster titration; MK-677 offers sustained plateau without re-dosing
- Pulsatility
- Preserved. Works within natural circadian rhythm
- Absent. Continuous exogenous input suppresses endogenous pulses
- Pulsatile GH may favour lipolysis and insulin sensitivity vs continuous GH
- Appetite Effect
- Marked increase (12–18% caloric intake rise)
- Minimal to none
- MK-677's ghrelin-mimetic action complicates body recomposition protocols
- Regulatory Status
- Research compound (not FDA-approved for human use)
- Prescription-only controlled substance (FDA-approved for GH deficiency, wasting)
- HGH requires prescriber oversight; MK-677 legal for research purposes only
- Cost (Typical Monthly)
- $80–$150 for research-grade 25mg daily
- $400–$1,200 for 2–4 IU daily HGH therapy
- MK-677 significantly less expensive for equivalent IGF-1 elevation
- Endogenous Suppression
- None. Amplifies natural GH secretion
- Significant. 40–60% reduction in endogenous GH pulse amplitude within 8 weeks
- MK-677 doesn't shut down pituitary function; HGH does if dosed continuously
- Professional Assessment
- Best for: long-term IGF-1 elevation without injections, protocols requiring preserved GH pulsatility, cost-sensitive research applications. Avoid if: appetite control critical, rapid titration needed, pituitary insufficiency present.
- Best for: rapid IGF-1 titration, pituitary insufficiency, clinical GH deficiency. Avoid if: injection aversion, regulatory constraints, budget limitations, long-term endogenous suppression undesirable.